Article

Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four.

Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Mechanisms of Development (impact factor: 2.83). 09/2007; 124(7-8):551-8. DOI:10.1016/j.mod.2007.05.004 pp.551-8
Source: PubMed

ABSTRACT Absence of the fibronectin (FN) gene leads to early embryonic lethality in both 129S4 and C57BL/6J strains due to severe cardiovascular defects. However, heart development is arrested at different stages in these embryos depending on the genetic background. In the majority of 129S4 FN-null embryos, heart progenitors remain at their anterior bilateral positions and fail to fuse at the midline to form a heart tube. However, on the C57BL/6J genetic background, cardiac development progresses further and results in a centrally positioned and looped heart. To find factor(s) involved in embryonic heart formation and governing the extent of heart development in FN-null embryos in 129S4 and C57BL/6J strains, we performed genetic mapping and haplotype analyses. These analyses lead to identification of a significant linkage to a 1-Mbp interval on chromosome four. Microarray analysis and sequencing identified 21 genes in this region, including five that are differentially expressed between the strains, as potential modifiers. Since none of these genes was previously known to play a role in heart development, one or more of them is likely to be a novel modifier affecting cardiac development. Identification of the modifier would significantly enhance our understanding of the molecular underpinning of heart development and disease.

0 0
 · 
0 Bookmarks
 · 
40 Views
  • Source
    Article: New insights into form and function of fibronectin splice variants.
    [show abstract] [hide abstract]
    ABSTRACT: The extracellular matrix (ECM) is a highly dynamic structure that not only provides a physical framework for cells within connective tissues, but also imparts instructive signals for development, tissue homeostasis and basic cell functions through its composition and ability to exert mechanical forces. The ECM of tissues is composed of, in addition to proteoglycans and hyaluronic acid, a number of proteins, most of which are generated after alternative splicing of their pre-mRNA. However, the precise function of these protein isoforms is still obscure in most cases. Fibronectin (FN), one of the main components of the ECM, is also one of the best-known examples of a family of proteins generated by alternative splicing, having at least 20 different isoforms in humans. Over the last few years, considerable progress on elucidating the functions of the alternatively spliced FN isoforms has been achieved with the essential development of key engineered mouse strains. Here we summarize the phenotypes of the mouse strains having targeted mutations in the FN gene, which may lead to novel insights linking function of alternatively spliced isoforms of fibronectin to human pathologies.
    The Journal of Pathology 10/2008; 216(1):1-14. · 6.32 Impact Factor

Full-text

View
0 Downloads
Available from

Keywords

1-Mbp interval
 
129S4 FN-null embryos
 
anterior bilateral positions
 
C57BL/6J genetic background
 
cardiac development
 
cardiac development progresses
 
centrally
 
different stages
 
differentially
 
embryonic heart formation
 
embryonic lethality
 
genes
 
genetic background
 
haplotype analyses
 
heart development
 
Microarray analysis
 
molecular underpinning
 
novel modifier
 
potential modifiers
 
severe cardiovascular defects
 

Sophie Astrof